London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: TGTBT, 3 Jan 2023 10:59
Last post: j5nicks, 13 Jun 2024 16:46
Hi Max, I had a lot of issues trying to find someone to convert, went to Citibank in the end and they guided me towards Stifel in the US who sorted everything out. If you’re still struggling reach out and I’ll try and dig out the contacts
Has anyone ever converted the ordinary shares to ADS after the transition in 2017?
I sill have some ordinary shares in my bank statment and the bank told me i have to find a broker to change it to ADS. However, i expect this involves huge costs and a bit discount. Has anyone some experience?
Many thanks j5nicks. Much appreciated.
Hi TGTBT, I believe the consolidation was 50/1 administered back in 2017. Since trading only on NASDAQ 8 x ordinary shares represents 1 ADS, hope this helps
HNY all! Great to see VRP going from strength to strength.
Grateful if anybody can advise what the dilution level was when this was a purely a UK listed company to listing on NASDAQ? My wife use to have 1.885m shares at an average of 1.8p. She now has just over 6.5k shares.
Thanks in advance for any help.
I simply changed mine through my London Broker. That minimal cost well repaid due to increase in SP.
Regards
Nice to hear from for Izstar and hope that you are keeping well. It’s a shame that you lost out, but I guess that’s the risks and choices associated with share dealing! Hindsight is a wonderful thing, as I realise that I sold too soon, but of course the SP could have tanked a few days after the trial success, and I have been caught out before!
Anyway, thank you for your reply and best wishes for 2023.
Started: Digger01, 21 Dec 2022 17:27
Last post: izstar, 4 Jan 2023 12:40
How lovely to hear from you Digger - we sure go back a long way
No, I was pi''ed off by the move to the US so sold out so lost a pretty massive sum here. I am however really pleased you hung on as I think Rhodi did too. Well done for trust and faith in the drug and I am very pleased you got your money back
All the very best to you Digger and Rhodi if you read this
It all came good in the end guys! Only 14 years for me and probably only made 20%, so allowing for inflation at 2% pa prior to 2021/23, I probably broke even. Sold out yesterday, a bit premature but happy to have finally got my money back.
I hope you guys managed to reap some benefit as well, after all this time.
Last post: Barbershop, 23 Dec 2022 19:27
Was hoping for $75 a share, not sure how realistic that is but will wait another 18 months to find out.
Some people on the stocktwits chat are talking $100 after NDA and the FCA approval - not sure if it'll happen but holding tightly...
I did manage to buy more shares under $5 back around end May/June, so have a nice profit so far, but I still think it has plenty of scope yet, and after 15 years another year or so doesn't seem too long to wait.
Check out the chat on stocktwits if you need any encouragement.
Where do people estimate this to be when the New Drug Application is approved - I have had these shares for well over 15 years now, and am going to hold till the end. Question is, when is the end, we have been so close to both success and failure over the years - it looks like we finally have some great results, and really nothing to stop us now. But how much is the share price worth when Ensifentrine comes to market?
Good news out. Interesting to see how this goes on US open.
Started: Digger01, 21 Dec 2022 17:17
Last post: Digger01, 21 Dec 2022 17:17
Like you Thomson, I have held these for 14 years but sold out yesterday. Probably a bit premature based on today’s move. However, I have been badly burnt twice Renx and AGl, with both releasing excellent results. The former moving from $30 to $2 having been shorted to hell on the basis of no revenue.
Although very well funded, again VRNA now valued at $1.4b which again is massive based on potential!
No advice from me, but watch carefully if you intend to hold to revenue!
Started: Barbershop, 19 Dec 2022 21:23
Last post: Barbershop, 19 Dec 2022 21:23
Started: Digger01, 15 Nov 2022 17:59
Last post: Digger01, 15 Nov 2022 17:59
Last post: Digger01, 28 Oct 2022 21:25
Finally starting to look interesting for long suffering holders.
Last post: Barbershop, 17 Oct 2022 09:34
Even more funding, but non-dilutive this time:
https://www.veronapharma.com/media/verona-pharma-secures-debt-financing-150-million-oxford-finance
Should see us through to commercialisation and hopefully a good return. In this one until the end...
Massive $150m raise, fully subscribed at $10.5 per ADS. Fully backed and funded
Started: Digger01, 11 Aug 2022 23:38
Last post: Digger01, 11 Aug 2022 23:38
Nice to hear from you Izstar!
It’s been a long long frustrating road, but it seems that things a starting to move along. New fund raise was a surprise based on their cash position, however , it was well supported at a good price of $10.5 and comfortably funds them through to commercialisation. Get me to $20 and I will be over the moon! I hope you are both well.
Started: rhodi, 11 Aug 2022 10:04
Last post: rhodi, 11 Aug 2022 10:04
Good to see you and Digger and unfortunately I believe confusion 2 may have sadly passed. Anyway I have to say I think I might have sold the entire holding at £14 had I still held my original amount. I have made the losses back from here but hopefully bewise is still in and doing well and some of the others who were regulars. Good health and continued prosperity on VRNA. Surprised they are seeming to do another fundraise. Is that correct as thought the cash flow was strong. Yes we will meet in Brum.
Like old times seeing you two on this just missing confusion 2. Sold all mine for a huge loss but like rhodi could not resist a small further holding so obviously pleased at recent development - well done digger for keeping the faith
ATB to you both and we will do that Brum get together!
Good to hear from you and hope you are well?
I need around $20 to break even, so a little way to go yet, but all looking good FINALLY!
Started: rhodi, 10 Aug 2022 02:46
Last post: rhodi, 10 Aug 2022 02:46
Holding is small here but still pleased that it is moving in right direction. All free carry so will wait and hope it gets to a higher level yet. Would not invest at this price but I am sure many will. Well done to those that may have clawed back their money and others that are well in profit. Hope izstar digger and all LTH's are in good health.
Last post: Digger01, 9 Aug 2022 20:39
Missed an opportunity to sell at $14, so I guess I will have to wait for results of Enhance 1 at year end!
Unless these results attract more investors in search of the larger prize.
Started: Barbershop, 9 Aug 2022 10:56
Last post: Barbershop, 9 Aug 2022 10:56
Started: Digger01, 8 Aug 2022 23:52
Last post: Barbershop, 9 Aug 2022 00:45
Seems to be reporting trial results much earlier than expected. Hopefully a good sign....
It's SHOWTIME!!!!
Shame Rhodi et al decided to bail when they did, looks like this might pay off for the lth...best of luck to us all...
Top line data presenting tomorrow! Good After market SP action.
Last post: Barbershop, 28 Jul 2022 19:24
Last top up today, just have to wait and see how things play out between now and end of year.
Can't see any reason why SP is as low as current level, but good top up price.
Shhhhhh but we seem to be building momentum towards the results of P3 Enhance 2, due this qtr.
Last post: Barbershop, 10 Jun 2022 16:02
Expect it'll be late August/early September when Enhance 2 results published given when enrolment completed and trial is 24 weeks.
I note that enrolment for Enhance P3 trials is complete. Enhance 2 data expected Q3 and Enhance 1 at year end. GL all LT holders.
I have bought a few VRNA to average down due to continued belief. I am also very happy that the P3 end point targets are based on FEV and general improvement in well being. FEV has always been good in every previous trial, so I personally believe that the prospects for success are good, and on that basis, I look forward to results
Started: Digger01, 4 Jun 2022 13:41
Last post: Thunderoad123, 6 Jun 2022 22:32
Thanks Digger.
Thanks a lot. I held quite a few for 10 years and when the price went low I added to it but it's never really bounced back. I jut hope i'm proved right eventually.
If you continued to hold in the hope of getting your money back you might just about do it...but if you are expecting a profit really had to top up when the SP hit the lows...
Just looks to me like a good time to get your average down as phase three results due over next 6 months and it looks like this is an attempt by the company to raise the profile ahead of results:
https://www.veronapharma.com/media/verona-pharma-host-kol-event-june-16-2022
Thanks Digger. So we're saying that the price is still less than 2p old money which is shocking. I do think that the Market Makers are manipulating this share as on Friday, people had bought 1000s and when someone sold a small amount of shares relative to purchases it plunged by 10%. Lets hope the estimate by the professional s of between £25-30 a share comes true this year.
Current SP $4.76 @ £1 = $1.25 = £3.81
8 shares per ADS @ £3.81/8 = £0.476
Then /50 so in “old Aim money” 0.95p
Do still under a penny. I agree that this investment has been a long painful journey, but this year for phase 3 results??
Started: Digger01, 3 Jun 2022 21:44
Last post: Thunderoad123, 3 Jun 2022 23:48
Thanks Digger and Barbershop. Barbershop just to clarify, as Digger mentioned the company felt that that it needed to stop being a penny share so we were given 1 share for every 8 we held. When Verona was listed on the Nasdaq it was 1 new share for 50 of the old shares which as I mentioned in my previous post currently puts the current old penny price (if that makes sense) at 1.25p which is shocking. I remember this share going up to 16p when it was a penny share which at todays rate would make it £60 per share. How the mighty have fallen. My loyalty to this bl**dy share has been so misplaced having been in it for 12 years now, I would have had more success buying a hog roast cart and setting it up outside a vegetarians convention. At least I'd still have the cart and the the pork.
You are correct!
50:1 was a dilution at some point before US listing.
I have held since 2009. I continued to add and need about $20 to break even. Not my best investment!
Started: Thunderoad123, 31 May 2022 18:29
Last post: Barbershop, 2 Jun 2022 18:37
When we dual listed on Nasdaq, each VRNA (ADS) share was comprised of 8 VRP shares...so you're right that if you held 8 AIM listed VRP shares you would get 1 VRNA share if you elected to continue holding.
Not sure where you're getting the 50:1 from as it was always 8:1
Can someone refresh my memory. I' m trying to equate back what the current share price in pence would be for verona pharma at the current approx price of £5. Am I right in thinking the american share was 1 share per 50 old shares which would make the current price 10p per share and then am I right in thinking that in the uk we got 1 new share per 8 old penny shares which would make the current price per share 1.25p per share which if true is ridiculous but maybe someone like Rhodi with a better memory than mine can correct me.. Many thanks
Started: Barbershop, 21 Apr 2022 15:17
Last post: Barbershop, 21 Apr 2022 15:17
Managed to top up with HL as Halifax don't seem to allow it.
Seems a great opportunity at these levels with Phase 3 results due by end of Q3 and again by end of Q4.
Started: rhodi, 6 Apr 2022 16:52
Last post: rhodi, 6 Apr 2022 16:52
Many an investor lowered their holding when the directors missed that opportunity. Like you say just one of a catalog of strewn errors. But hey if I can keep accumulating free shares then happy as Larry. There was a very knowledgeable poster on ADVFN that relinquished shares and was totally mystified at the missed "opportunity" as you quite correctly state.